Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.25
-3.3%
$0.32
$0.25
$1.32
$15.13M4.791.04 million shs1.08 million shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.50
-0.8%
$2.68
$2.33
$4.96
$15.69M0.3821,210 shs6,876 shs
Scienture Holdings, Inc. stock logo
SCNX
Scienture
$0.38
-4.1%
$0.39
$0.24
$2.60
$15.24M3.292.14 million shs354,726 shs
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
$2.21
+0.5%
$2.35
$1.73
$7.05
$3.83M0.74755,372 shs7,327 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cosmos Health Inc. stock logo
COSM
Cosmos Health
+3.33%-0.61%-31.24%-32.49%-43.14%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.00%-1.18%-7.35%-9.03%-23.77%
Scienture Holdings, Inc. stock logo
SCNX
Scienture
-1.36%-2.28%-2.57%-2.28%-55.58%
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
+0.41%-5.95%-19.82%+12.04%-52.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$0.25
-3.3%
$0.32
$0.25
$1.32
$15.13M4.791.04 million shs1.08 million shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.50
-0.8%
$2.68
$2.33
$4.96
$15.69M0.3821,210 shs6,876 shs
Scienture Holdings, Inc. stock logo
SCNX
Scienture
$0.38
-4.1%
$0.39
$0.24
$2.60
$15.24M3.292.14 million shs354,726 shs
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
$2.21
+0.5%
$2.35
$1.73
$7.05
$3.83M0.74755,372 shs7,327 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cosmos Health Inc. stock logo
COSM
Cosmos Health
+3.33%-0.61%-31.24%-32.49%-43.14%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.00%-1.18%-7.35%-9.03%-23.77%
Scienture Holdings, Inc. stock logo
SCNX
Scienture
-1.36%-2.28%-2.57%-2.28%-55.58%
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
+0.41%-5.95%-19.82%+12.04%-52.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cosmos Health Inc. stock logo
COSM
Cosmos Health
1.00
SellN/AN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
1.00
SellN/AN/A
Scienture Holdings, Inc. stock logo
SCNX
Scienture
2.00
Hold$1.50300.00% Upside
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest XRTX, NAII, COSM, and SCNX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/26/2026
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
Reiterated RatingSell (E+)
3/27/2026
Scienture Holdings, Inc. stock logo
SCNX
Scienture
Reiterated RatingSell (E+)
3/27/2026
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
Reiterated RatingSell (E+)
(Data available from 6/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cosmos Health Inc. stock logo
COSM
Cosmos Health
$65.27M0.23N/AN/A$0.45 per share0.56
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$141.87M0.11N/AN/A$11.07 per share0.23
Scienture Holdings, Inc. stock logo
SCNX
Scienture
$430K35.43N/AN/A$1.73 per share0.22
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
N/AN/AN/AN/A$1.50 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$19.15M-$0.64N/A3.60N/A-30.41%-52.85%-17.87%8/17/2026 (Estimated)
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
-$13.57M-$2.39N/AN/AN/A-10.13%-12.21%-5.30%N/A
Scienture Holdings, Inc. stock logo
SCNX
Scienture
-$41.51M-$2.51N/AN/AN/AN/A-56.28%-44.76%8/17/2026 (Estimated)
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
-$2.66M-$2.63N/AN/AN/AN/A-150.01%-106.53%8/13/2026 (Estimated)

Latest XRTX, NAII, COSM, and SCNX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2026Q1 2026
Cosmos Health Inc. stock logo
COSM
Cosmos Health
-$0.06-$0.06N/A-$0.06$17.93 million$18.40 million
5/18/2026Q3 2026
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/A-$0.72N/A-$0.72N/A$35.48 million
5/15/2026Q1 2026
Scienture Holdings, Inc. stock logo
SCNX
Scienture
-$0.23-$0.08+$0.15-$0.08$0.40 million$0.06 million
5/15/2026Q1 2026
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
N/A-$0.58N/A-$0.58N/AN/A
3/30/2026Q4 2025
Scienture Holdings, Inc. stock logo
SCNX
Scienture
-$0.28-$1.76-$1.48-$1.76$0.49 million($0.17) million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cosmos Health Inc. stock logo
COSM
Cosmos Health
N/AN/AN/AN/AN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/AN/A
Scienture Holdings, Inc. stock logo
SCNX
Scienture
N/AN/AN/AN/AN/A
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
$0.3013.57%N/AN/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cosmos Health Inc. stock logo
COSM
Cosmos Health
0.31
1.08
0.92
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.13
1.64
0.87
Scienture Holdings, Inc. stock logo
SCNX
Scienture
N/A
1.70
1.63
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
N/A
0.86
0.86

Institutional Ownership

CompanyInstitutional Ownership
Cosmos Health Inc. stock logo
COSM
Cosmos Health
12.61%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
32.40%
Scienture Holdings, Inc. stock logo
SCNX
Scienture
5.68%
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
0.23%

Insider Ownership

CompanyInsider Ownership
Cosmos Health Inc. stock logo
COSM
Cosmos Health
25.10%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
20.80%
Scienture Holdings, Inc. stock logo
SCNX
Scienture
21.39%
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cosmos Health Inc. stock logo
COSM
Cosmos Health
10059.96 million44.91 millionOptionable
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
2906.28 million4.97 millionNot Optionable
Scienture Holdings, Inc. stock logo
SCNX
Scienture
N/A40.63 million31.94 millionN/A
XORTX Therapeutics Inc. stock logo
XRTX
XORTX Therapeutics
N/A1.73 million1.61 millionNot Optionable

Recent News About These Companies

XORTX Announces Closing of US$5 Million Public Offering
XORTX Announces US$5 Million Public Offering
XORTX Announces US$5 Million Public Offering
XORTX Meets Nasdaq Continued Listing Requirements
XORTX Confirms Effective Date of Share Consolidation
XORTX Confirms Effective Date of Share Consolidation
XORTX Confirms Effective Date of Share Consolidation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cosmos Health stock logo

Cosmos Health NASDAQ:COSM

$0.25 -0.01 (-3.33%)
As of 12:57 PM Eastern

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Natural Alternatives International stock logo

Natural Alternatives International NASDAQ:NAII

$2.50 -0.02 (-0.79%)
As of 12:55 PM Eastern

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.

Scienture stock logo

Scienture NASDAQ:SCNX

$0.38 -0.02 (-4.07%)
As of 12:56 PM Eastern

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.

XORTX Therapeutics stock logo

XORTX Therapeutics NASDAQ:XRTX

$2.21 +0.01 (+0.45%)
As of 12:32 PM Eastern

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.